<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38425701</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1980-5764</ISSN><JournalIssue CitedMedium="Print"><Volume>18</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Dementia &amp; neuropsychologia</Title><ISOAbbreviation>Dement Neuropsychol</ISOAbbreviation></Journal><ArticleTitle>Long COVID: neurological manifestations - an updated narrative review.</ArticleTitle><Pagination><StartPage>e20230076</StartPage><MedlinePgn>e20230076</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e20230076</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/1980-5764-DN-2023-0076</ELocationID><Abstract><AbstractText>Infection with the SARS-CoV-2 virus can lead to neurological symptoms in the acute phase and in the Long COVID phase. These symptoms usually involve cognition, sleep, smell disorders, psychiatric manifestations, headache and others. This condition is more commonly described in young adults and women. This symptomatology can follow severe or mild cases of the disease. The importance of this issue resides in the high prevalence of neurological symptoms in the Long COVID phase, which entails significant morbidity in this population. In addition, such a condition is associated with high health care costs, with some estimates hovering around 3.7 trillion US dollars. In this review, we will sequentially describe the current knowledge about the most prevalent neurological symptoms in Long COVID, as well as their pathophysiology and possible biomarkers.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Leonel</LastName><ForeName>Jos&#xe9; Wagner</ForeName><Initials>JW</Initials><Identifier Source="ORCID">0000-0002-7405-4998</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciurleo</LastName><ForeName>Gabriella Cunha Vieira</ForeName><Initials>GCV</Initials><Identifier Source="ORCID">0000-0001-9420-8723</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Formiga</LastName><ForeName>Alissa Moura</ForeName><Initials>AM</Initials><Identifier Source="ORCID">0000-0002-2613-2568</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vasconcelos</LastName><ForeName>Thais de Maria Frota</ForeName><Initials>TMF</Initials><Identifier Source="ORCID">0000-0001-5469-3111</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Andrade</LastName><ForeName>Marcello Holanda</ForeName><Initials>MH</Initials><Identifier Source="ORCID">0000-0002-2714-9505</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feitosa</LastName><ForeName>Werbety Lucas Queiroz</ForeName><Initials>WLQ</Initials><Identifier Source="ORCID">0000-0003-1154-257X</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira-Neto</LastName><ForeName>Ant&#xf4;nio Alves</ForeName><Initials>AA</Initials><Identifier Source="ORCID">0000-0002-0277-0354</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Portugal</LastName><ForeName>Chiara G&#xfc;bel</ForeName><Initials>CG</Initials><Identifier Source="ORCID">0000-0002-4795-9871</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morais</LastName><ForeName>Lorenzo Marinho</ForeName><Initials>LM</Initials><Identifier Source="ORCID">0000-0003-4769-9042</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marinho</LastName><ForeName>Samuel Cavalcante</ForeName><Initials>SC</Initials><Identifier Source="ORCID">0000-0002-6502-747X</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Emanuel de Assis Bertulino Martins</ForeName><Initials>EABM</Initials><Identifier Source="ORCID">0009-0006-1836-8219</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feitosa</LastName><ForeName>Esther de Alencar Araripe Falc&#xe3;o</ForeName><Initials>EAAF</Initials><Identifier Source="ORCID">0000-0003-1447-7320</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira</LastName><ForeName>Emmanuelle Silva Tavares</ForeName><Initials>EST</Initials><Identifier Source="ORCID">0000-0002-6017-5107</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ori&#xe1;</LastName><ForeName>Reinaldo Barreto</ForeName><Initials>RB</Initials><Identifier Source="ORCID">0000-0002-6914-5481</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobreira-Neto</LastName><ForeName>Manoel Alves</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0001-9619-6551</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braga-Neto</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9186-9243</Identifier><AffiliationInfo><Affiliation>Universidade Federal do Cear&#xe1;, Fortaleza CE, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Dement Neuropsychol</MedlineTA><NlmUniqueID>101506587</NlmUniqueID><ISSNLinking>1980-5764</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="por"><AbstractText>A infec&#xe7;&#xe3;o pelo v&#xed;rus SARS-CoV-2 pode levar a sintomas neurol&#xf3;gicos na fase aguda e na fase de COVID longa. Esses sintomas geralmente envolvem cogni&#xe7;&#xe3;o, sono, dist&#xfa;rbios do olfato, manifesta&#xe7;&#xf5;es psiqui&#xe1;tricas, dor de cabe&#xe7;a e outros. Esta condi&#xe7;&#xe3;o &#xe9; mais comumente descrita em adultos jovens e mulheres. A sintomatologia pode acompanhar casos graves ou leves da doen&#xe7;a. A import&#xe2;ncia desta quest&#xe3;o reside na elevada preval&#xea;ncia de sintomas neurol&#xf3;gicos na fase de COVID longa, o que acarreta morbilidade significativa nesta popula&#xe7;&#xe3;o. Al&#xe9;m disso, tal condi&#xe7;&#xe3;o est&#xe1; associada a elevados custos de cuidados de sa&#xfa;de, com algumas estimativas em torno de 3,7 trilh&#xf5;es de d&#xf3;lares americanos. Nesta revis&#xe3;o, descrevemos sequencialmente o conhecimento atual sobre os sintomas neurol&#xf3;gicos mais prevalentes na COVID longa, bem como sua fisiopatologia e poss&#xed;veis biomarcadores.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognition</Keyword><Keyword MajorTopicYN="N">Cognitive Dysfunction</Keyword><Keyword MajorTopicYN="N">Post-Acute COVID-19 Syndrome</Keyword></KeywordList><CoiStatement>Disclosure: The authors report no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>1</Day><Hour>3</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38425701</ArticleId><ArticleId IdType="pmc">PMC10901563</ArticleId><ArticleId IdType="doi">10.1590/1980-5764-DN-2023-0076</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou H, Lu S, Chen J, Wei N, Wang D, Lyu H, et al. The landscape of cognitive function in recovered COVID-19 patients. J Psychiatr Res. 2020;129:98&#x2013;102. doi: 10.1016/j.jpsychires.2020.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2020.06.022</ArticleId><ArticleId IdType="pmc">PMC7324344</ArticleId><ArticleId IdType="pubmed">32912598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior JWL, Oliveira DN, Silva JBS, Feitosa WLQ, Sousa AVM, Cunha LCV, et al. Long-covid cognitive impairment: Cognitive assessment and apolipoprotein E (APOE) genotyping correlation in a Brazilian cohort. Front Psychiatry. 2022;13:947583&#x2013;947583. doi: 10.3389/fpsyt.2022.947583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947583</ArticleId><ArticleId IdType="pmc">PMC9423011</ArticleId><ArticleId IdType="pubmed">36046159</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior JWL, Souza ACC, Borges JWP, Oliveira DN, Siqueira-Neto JI, Sobreira-Neto MA, et al. COVID-19 associated cognitive impairment: a systematic review. Cortex. 2022;152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior JWL, Coimbra PPA, Braga-Neto P. Post Coronavirus disease 2019 vaccine-associated acute myeloradiculoneuropathy responsive to plasmapheresis. Rev Soc Bras Med Trop. 2022;55:e0015. doi: 10.1590/0037-8682-0015-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0037-8682-0015-2022</ArticleId><ArticleId IdType="pmc">PMC9176725</ArticleId><ArticleId IdType="pubmed">35674552</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura AEF, Oliveira DN, Torres DM, Tavares-J&#xfa;nior JWL, N&#xf3;brega PR, Braga-Neto P, et al. Central hypersomnia and chronic insomnia: expanding the spectrum of sleep disorders in long COVID syndrome - a prospective cohort study. BMC Neurol. 2022;22(1):417&#x2013;417. doi: 10.1186/s12883-022-02940-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-022-02940-7</ArticleId><ArticleId IdType="pmc">PMC9643986</ArticleId><ArticleId IdType="pubmed">36352367</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. Nat Rev Microbiol. 2023;21(3):133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: a prospective study. Eur J Neurol. 2022;29(4):1218&#x2013;1221. doi: 10.1111/ene.15215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15215</ArticleId><ArticleId IdType="pubmed">34918425</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-S&#xe1;nchez C, Calabria M, Grunden N, Pons C, Arroyo JA, G&#xf3;mez-Anson B, et al. Neuropsychological deficits in patients with cognitive complaints after COVID-19. Brain Behav. 2022;12(3):e2508. doi: 10.1002/brb3.2508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2508</ArticleId><ArticleId IdType="pmc">PMC8933779</ArticleId><ArticleId IdType="pubmed">35137561</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav Immun. 2022;101:93&#x2013;135. doi: 10.1016/j.bbi.2021.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med (Lausanne) 2023;10:1187163&#x2013;1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler DM. The costs of long COVID. JAMA Health Forum. 2022;3(5):e221809. doi: 10.1001/jamahealthforum.2022.1809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior JWL, Oliveira DN, Silva JBS, Feitosa WLQ, Sousa AVM, Marinho SC, et al. Post-COVID-19 cognitive decline and apoe polymorphism: towards a possible link? Brain Sci. 2023;13(12):1611&#x2013;1611. doi: 10.3390/brainsci13121611.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13121611</ArticleId><ArticleId IdType="pmc">PMC10742128</ArticleId><ArticleId IdType="pubmed">38137059</ArticleId></ArticleIdList></Reference><Reference><Citation>Negrini F, Ferrario I, Mazziotti D, Berchicci M, Bonazzi M, Sire A, et al. Neuropsychological features of severe hospitalized Coronavirus disease 2019 patients at clinical stability and clues for postacute rehabilitation. Arch Phys Med Rehabil. 2021;102(1):155&#x2013;158. doi: 10.1016/j.apmr.2020.09.376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apmr.2020.09.376</ArticleId><ArticleId IdType="pmc">PMC7521874</ArticleId><ArticleId IdType="pubmed">32991870</ArticleId></ArticleIdList></Reference><Reference><Citation>Matias-Guiu JA, Herrera E, Gonz&#xe1;lez-Nosti M, Krishnan K, Delgado-&#xc1;lvarez C, D&#xed;ez-Cirarda M, et al. Development of criteria for cognitive dysfunction in post-COVID syndrome: the IC-CoDi-COVID approach. Psychiatry Res. 2023;319:115006&#x2013;115006. doi: 10.1016/j.psychres.2022.115006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.115006</ArticleId><ArticleId IdType="pubmed">36521337</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L, Calandri I, Corval&#xe1;n N, Carello MA, Keller G, Mart&#xed;nez C, et al. Cognitive consequences of COVID-19: results of a cohort study from South America. Arq Neuropsiquiatr. 2022;80(3):240&#x2013;247. doi: 10.1590/0004-282X-ANP-2021-0320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X-ANP-2021-0320</ArticleId><ArticleId IdType="pmc">PMC9648931</ArticleId><ArticleId IdType="pubmed">34816972</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Alonso C, Valles-Salgado M, Delgado-&#xc1;lvarez A, Yus M, G&#xf3;mez-Ruiz N, Jorquera M, et al. Cognitive dysfunction associated with COVID-19: a comprehensive neuropsychological study. J Psychiatr Res. 2022;150:40&#x2013;46. doi: 10.1016/j.jpsychires.2022.03.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2022.03.033</ArticleId><ArticleId IdType="pmc">PMC8943429</ArticleId><ArticleId IdType="pubmed">35349797</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, Kremer S, Merdji H, Clere-Jehl R, Schenck M, Kummerlen C, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382(23):2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Delorme C, Paccoud O, Kas A, Hesters A, Bombois S, Shambrook P, et al. COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings. Eur J Neurol. 2020;27(12):2651&#x2013;2657. doi: 10.1111/ene.14478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14478</ArticleId><ArticleId IdType="pmc">PMC7461074</ArticleId><ArticleId IdType="pubmed">32881133</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaywant A, Vanderlind WM, Alexopoulos GS, Fridman CB, Perlis RH, Gunning FM. Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology. 2021;46(13):2235&#x2013;2240. doi: 10.1038/s41386-021-00978-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41386-021-00978-8</ArticleId><ArticleId IdType="pmc">PMC7884062</ArticleId><ArticleId IdType="pubmed">33589778</ArticleId></ArticleIdList></Reference><Reference><Citation>Rass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, et al. Neurological outcome and quality of life 3 months after COVID-19: a prospective observational cohort study. Eur J Neurol. 2021;28(10):3348&#x2013;3359. doi: 10.1111/ene.14803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14803</ArticleId><ArticleId IdType="pmc">PMC8250725</ArticleId><ArticleId IdType="pubmed">33682276</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 &#x201c;long haulers&#x201d;. Ann Clin Transl Neurol. 2021;8(5):1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch S, Ferrando SJ, Dornbush R, Shahar S, Smiley A, Klepacz L. Screening for brain fog: is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19? Gen Hosp Psychiatry. 2022;78:80&#x2013;86. doi: 10.1016/j.genhosppsych.2022.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2022.07.013</ArticleId><ArticleId IdType="pmc">PMC9359801</ArticleId><ArticleId IdType="pubmed">35930974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballouz T, Menges D, Anagnostopoulos A, Domenghino A, Aschmann HE, Frei A, et al. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study. BMJ. 2023;381:e074425. doi: 10.1136/bmj-2022-074425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-074425</ArticleId><ArticleId IdType="pmc">PMC10230608</ArticleId><ArticleId IdType="pubmed">37257891</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorent N, Weygaerde YV, Claeys E, Fajardo IGC, De Vos N, De Wever W, et al. Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge. ERJ Open Res. 2022;8(2):00004&#x2013;02022. doi: 10.1183/23120541.00004-2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/23120541.00004-2022</ArticleId><ArticleId IdType="pmc">PMC8994962</ArticleId><ArticleId IdType="pubmed">35415186</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 2020;19(11):919&#x2013;929. doi: 10.1016/S1474-4422(20)30308-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30308-2</ArticleId><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik JJ, Bileck A, Hagn G, Meier-Menches SM, Frey T, Kaempf A, et al. A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. iScience. 2023;26(1):105717&#x2013;105717. doi: 10.1016/j.isci.2022.105717.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="pubmed">36507225</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MH, Perl DP, Steiner J, Pasternack N, Li W, Maric D, et al. Neurovascular injury with complement activation and inflammation in COVID-19. Brain. 2022;145(7):2555&#x2013;2568. doi: 10.1093/brain/awac151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac151</ArticleId><ArticleId IdType="pmc">PMC9278212</ArticleId><ArticleId IdType="pubmed">35788639</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, Lee S, Alfaro-Almagro F, Arthofer C, Wang C, McCarthy P, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai YJ, Liu SH, Manachevakul S, Lee TA, Kuo CT, Bello D. Biomarkers in long COVID-19: a systematic review. Front Med (Lausanne) 2023;10:1085988&#x2013;1085988. doi: 10.3389/fmed.2023.1085988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1085988</ArticleId><ArticleId IdType="pmc">PMC9895110</ArticleId><ArticleId IdType="pubmed">36744129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hugon J, Queneau M, Ortiz MS, Msika EF, Farid K, Paquet C. Cognitive decline and brainstem hypometabolism in long COVID: a case series. Brain Behav. 2022;12(4):e2513. doi: 10.1002/brb3.2513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.2513</ArticleId><ArticleId IdType="pmc">PMC9014998</ArticleId><ArticleId IdType="pubmed">35290729</ArticleId></ArticleIdList></Reference><Reference><Citation>Safan AS, Imam Y, Khatib MY, Al Wraidat M, Altermanini MM, Al-Mughalles SA, et al. COVID-19-associated neurological sequelae: a case series on cerebral microbleeds and encephalopathy. Qatar Med J. 2023;2023(4):29&#x2013;29. doi: 10.5339/qmj.2023.29.</Citation><ArticleIdList><ArticleId IdType="doi">10.5339/qmj.2023.29</ArticleId><ArticleId IdType="pmc">PMC10618109</ArticleId><ArticleId IdType="pubmed">37920783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim WSH, Ji X, Roudaia E, Chen JJ, Gilboa A, Sekuler A, et al. MRI assessment of cerebral blood flow in nonhospitalized adults who self-isolated due to COVID-19. J Magn Reson Imaging. 2023;58(2):593&#x2013;602. doi: 10.1002/jmri.28555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.28555</ArticleId><ArticleId IdType="pmc">PMC9877942</ArticleId><ArticleId IdType="pubmed">36472248</ArticleId></ArticleIdList></Reference><Reference><Citation>Teller N, Chad JA, Wong A, Gunraj H, Ji X, MacIntosh BJ, et al. Sensitivity of diffusion-tensor and correlated diffusion imaging to white-matter microstructural abnormalities: application in COVID-19. bioRxiv. 2022:1&#x2013;23. doi: 10.1101/2022.09.29.510004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.09.29.510004</ArticleId><ArticleId IdType="pmc">PMC10258529</ArticleId><ArticleId IdType="pubmed">37162380</ArticleId></ArticleIdList></Reference><Reference><Citation>Low RN, Low RJ, Akrami A. A review of cytokine-based pathophysiology of long COVID symptoms. Front Med (Lausanne) 2023;10:1011936&#x2013;1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, et al. Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection. Neurology(R) neuroimmunology &amp; neuroinflammation. 2022 Sep;14(5):9&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Sans HM, Forman CA, Nylander AN, Ho HE, Lu S, et al. Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2022;9(5):e200003. doi: 10.1212/NXI.0000000000200003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000200003</ArticleId><ArticleId IdType="pmc">PMC9210548</ArticleId><ArticleId IdType="pubmed">35701186</ArticleId></ArticleIdList></Reference><Reference><Citation>Crunfli F, Carregari VC, Veras FP, Vendramini PH, Valen&#xe7;a AGF, Antunes ASLM, et al. Morphological, cellular and molecular basis of brain infection in COVID-19 patients. medRxiv. 2020 doi: 10.1101/2020.10.09.20207464.2020.10.09.20207464</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.09.20207464</ArticleId><ArticleId IdType="pmc">PMC9436354</ArticleId><ArticleId IdType="pubmed">35951647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrara F, Zovi A, Masi M, Langella R, Trama U, Boccellino M, et al. Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn Schmiedebergs Arch Pharmacol. 2023;396(7):1583&#x2013;1589. doi: 10.1007/s00210-023-02417-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00210-023-02417-5</ArticleId><ArticleId IdType="pmc">PMC9918819</ArticleId><ArticleId IdType="pubmed">36773054</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs LG, Paleoudis EG, Bari DLD, Nyirenda T, Friedman T, Gupta A, et al. Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection. PLoS One. 2020;15(12):e0243882. doi: 10.1371/journal.pone.0243882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0243882</ArticleId><ArticleId IdType="pmc">PMC7732078</ArticleId><ArticleId IdType="pubmed">33306721</ArticleId></ArticleIdList></Reference><Reference><Citation>Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PLoS One. 2014;9(9):e108489. doi: 10.1371/journal.pone.0108489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0108489</ArticleId><ArticleId IdType="pmc">PMC4180737</ArticleId><ArticleId IdType="pubmed">25264897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta R, Pandi-Perumal SR. COVID-Somnia: how the pandemic affects sleep/wake regulation and how to deal with it? Sleep Vigil. 2020;4(2):51&#x2013;53. doi: 10.1007/s41782-020-00118-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41782-020-00118-0</ArticleId><ArticleId IdType="pmc">PMC7711056</ArticleId><ArticleId IdType="pubmed">33289005</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xu Z, Wang P, Li XM, Shuai ZW, Ye DQ, et al. New-onset autoimmune phenomena post-COVID-19 vaccination. Immunology. 2022;165(4):386&#x2013;401. doi: 10.1111/imm.13443.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.13443</ArticleId><ArticleId IdType="pubmed">34957554</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#x10d;i&#x107; M, Mar&#x10d;i&#x107; L, Mar&#x10d;i&#x107; B. SARS-CoV-2 infection causes relapse of Kleine-Levin Syndrome: case report and review of literature. Neurol Int. 2021;13(3):328&#x2013;334. doi: 10.3390/neurolint13030033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/neurolint13030033</ArticleId><ArticleId IdType="pmc">PMC8299328</ArticleId><ArticleId IdType="pubmed">34294673</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez FX, Flygare J, Grandner MA. Narcolepsy and COVID-19: sleeping on an opportunity? J Clin Sleep Med. 2020;16(8):1415&#x2013;1415. doi: 10.5664/jcsm.8520.</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.8520</ArticleId><ArticleId IdType="pmc">PMC7446099</ArticleId><ArticleId IdType="pubmed">32347205</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovitz B, Jaywant A, Fridman CB. Neuropsychological functioning in severe acute respiratory disorders caused by the coronavirus: implications for the current COVID-19 pandemic. Clin Neuropsychol. 2020;34(7-8):1453&#x2013;1479. doi: 10.1080/13854046.2020.1803408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13854046.2020.1803408</ArticleId><ArticleId IdType="pubmed">32901580</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson-Agramonte MA, Gon&#xe7;alves CA, Noris-Garc&#xed;a E, Rivero NP, Brigida AL, Schultz S, et al. Impact of SARS-CoV-2 on neuropsychiatric disorders. World J Psychiatry. 2021;11(7):347&#x2013;354. doi: 10.5498/wjp.v11.i7.347.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v11.i7.347</ArticleId><ArticleId IdType="pmc">PMC8311516</ArticleId><ArticleId IdType="pubmed">34327127</ArticleId></ArticleIdList></Reference><Reference><Citation>Damiano RF, Brand&#xe3;o D, Neto, Oliveira JVR, Santos JM, Alves JVR, Guedes BF, et al. Association between chemosensory impairment with neuropsychiatric morbidity in post-acute COVID-19 syndrome: results from a multidisciplinary cohort study. Eur Arch Psychiatry Clin Neurosci. 2023;273(2):325&#x2013;333. doi: 10.1007/s00406-022-01427-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00406-022-01427-3</ArticleId><ArticleId IdType="pmc">PMC9142732</ArticleId><ArticleId IdType="pubmed">35633395</ArticleId></ArticleIdList></Reference><Reference><Citation>Widmann CN, Kolano J, Peper M. Improving neuropsychological rehabilitation for COVID-19 patients. Zeitschrift f&#xfc;r Neuropsychologie. 2023;34(2):57&#x2013;70. doi: 10.1024/1016-264X/a000373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1024/1016-264X/a000373</ArticleId></ArticleIdList></Reference><Reference><Citation>Diana L, Regazzoni R, Sozzi M, Piconi S, Borghesi L, Lazzaroni E, et al. Monitoring cognitive and psychological alterations in COVID-19 patients: a longitudinal neuropsychological study. J Neurol Sci. 2023;444:120511&#x2013;120511. doi: 10.1016/j.jns.2022.120511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120511</ArticleId><ArticleId IdType="pmc">PMC9707027</ArticleId><ArticleId IdType="pubmed">36473347</ArticleId></ArticleIdList></Reference><Reference><Citation>Busatto GF, Araujo AL, Castaldelli-Maia JM, Damiano RF, Imamura M, Guedes BF, et al. Post-acute sequelae of SARS-CoV-2 infection: relationship of central nervous system manifestations with physical disability and systemic inflammation. Psychol Med. 2022;52(12):2389&#x2013;2398. doi: 10.1017/S0033291722001374.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722001374</ArticleId><ArticleId IdType="pmc">PMC9151630</ArticleId><ArticleId IdType="pubmed">35521752</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay A. A paradigm for post-Covid-19 fatigue syndrome analogous to ME/CFS. Front Neurol. 2021;12:701419&#x2013;701419. doi: 10.3389/fneur.2021.701419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.701419</ArticleId><ArticleId IdType="pmc">PMC8365156</ArticleId><ArticleId IdType="pubmed">34408721</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055&#x2013;110055. doi: 10.1016/j.mehy.2020.110055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110055</ArticleId><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Sankowski R, Mader S, Vald&#xe9;s-Ferrer SI. Systemic inflammation and the brain: Novel roles of genetic, molecular, and environmental cues as drivers of neurodegeneration. Front Cell Neurosci. 2015;9:28&#x2013;28. doi: 10.3389/fncel.2015.00028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00028</ArticleId><ArticleId IdType="pmc">PMC4313590</ArticleId><ArticleId IdType="pubmed">25698933</ArticleId></ArticleIdList></Reference><Reference><Citation>Yachou Y, El Idrissi A, Belapasov V, Ait Benali S. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients. Neurol Sci. 2020;41(10):2657&#x2013;2669. doi: 10.1007/s10072-020-04575-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04575-3</ArticleId><ArticleId IdType="pmc">PMC7385206</ArticleId><ArticleId IdType="pubmed">32725449</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacomy H, Fragoso G, Almazan G, Mushynski WE, Talbot PJ. Human coronavirus OC43 infection induces chronic encephalitis leading to disabilities in BALB/C mice. Virology. 2006;349(2):335&#x2013;346. doi: 10.1016/j.virol.2006.01.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2006.01.049</ArticleId><ArticleId IdType="pmc">PMC7111850</ArticleId><ArticleId IdType="pubmed">16527322</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh HO, Singh A, Khan AA, Gupta V. Immune mediating molecules and pathogenesis of COVID-19-associated neurological disease. Microbial Pathog. 2021;158:105023&#x2013;105023. doi: 10.1016/j.micpath.2021.105023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micpath.2021.105023</ArticleId><ArticleId IdType="pmc">PMC8177310</ArticleId><ArticleId IdType="pubmed">34090983</ArticleId></ArticleIdList></Reference><Reference><Citation>Achar A, Ghosh C. COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain relevance. Cells. 2020;9(11):2360&#x2013;2360. doi: 10.3390/cells9112360.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112360</ArticleId><ArticleId IdType="pmc">PMC7692725</ArticleId><ArticleId IdType="pubmed">33120941</ArticleId></ArticleIdList></Reference><Reference><Citation>Sodagar A, Javed R, Tahir H, Razak SIA, Shakir M, Naeem M, et al. Pathological features and neuroinflammatory mechanisms of SARS-CoV-2 in the brain and potential therapeutic approaches. Biomolecules. 2022;12(7):971&#x2013;971. doi: 10.3390/biom12070971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12070971</ArticleId><ArticleId IdType="pmc">PMC9313047</ArticleId><ArticleId IdType="pubmed">35883527</ArticleId></ArticleIdList></Reference><Reference><Citation>Borsetto D, Hopkins C, Philips V, Obholzer R, Tirelli G, Polesel J, et al. Self-reported alteration of sense of smell or taste in patients with COVID-19: a systematic review and meta-analysis on 3563 patients. Rhinology. 2020;58(5):430&#x2013;436. doi: 10.4193/Rhin20.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.4193/Rhin20.185</ArticleId><ArticleId IdType="pubmed">32626853</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafar A, Lasso A, Shorr R, Hutton B, Kilty S. Olfactory recovery following infection with COVID-19: A systematic review. PLoS One. 2021;16(11):e0259321. doi: 10.1371/journal.pone.0259321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259321</ArticleId><ArticleId IdType="pmc">PMC8577770</ArticleId><ArticleId IdType="pubmed">34752471</ArticleId></ArticleIdList></Reference><Reference><Citation>Doty RL. Olfactory dysfunction in COVID-19: pathology and long-term implications for brain health. Trends Mol Med. 2022;28(9):781&#x2013;794. doi: 10.1016/j.molmed.2022.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2022.06.005</ArticleId><ArticleId IdType="pmc">PMC9212891</ArticleId><ArticleId IdType="pubmed">35810128</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>